Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 289-300 of 1464 results.
"Recent research has indicated that a new type of medical device, the force-activated separation device (FASD), may reduce these mechanical complications by 46%, but efficacy and safety data are lacking. The objective of this study was to investigate the efficacy and rate of adverse events (AEs) using a novel FASD" Blacker et al (2025).
"This narrative review examines the existing literature on CVC management post-HSCT, highlighting key factors influencing the removal timing, such as patient characteristics, disease-specific considerations, and institutional practices" Cook et al (2025).
"We aimed to introduce a mixed methods approach to identify off-label indications for antimicrobials in specific settings, and applied this to an antimicrobial not commonly used in the Netherlands, ceftaroline" Stoorvogel et al (2025).
"For breast cancer patients, the ultrasound-guided AxV approach for TIVAP provides superior early postoperative comfort, long-term cosmetic results, and patient satisfaction without increasing early complication risks, representing a significant patient-centered advancement in venous access" He et al (2025).
"Although LPCs did not significantly reduce the need for repeated venipunctures, they demonstrated more favorable performance in routine Emergency Department practice" Binda et al (2025).
"This QIP highlights that carefully planned educational interventions, training, and hands-on practice can have on NICU healthcare providers' adherence to aseptic procedures. We found that frequent skills assessments with uncomplicated, easy-to-remember procedures can ensure that our system operates near maximum efficiency" Shahbaz et al (2025).
"These results suggest that proper infection control and careful management are essential during PPN therapy, especially when multiple vitamin products are used over extended periods" Miura et al (2025).
"In this study, the incidence of peripheral intravenous cannula-induced phlebitis was high, with a lower median time of phlebitis onset. The key predictors were female sex, large cannula, receipt of a blood transfusion, and administration of potassium chloride and vancomycin" Beyene et al (2025).
"This study aimed to compare the effects of taurolidine-citrate and unfractionated heparin lock solutions on catheter function, infection and thrombosis rates, and inflammatory markers in children with malignancies" Eghbali et al (2025).
"The BD PosiFlush SafeScrub, with its integrated disinfection unit, yielded approximately double the scrub-the-hub compliance (34%) before flushing compared to the standard practice of alcohol pads and pre-filled saline syringes (17%), supporting its role in facilitating adherence to ANTT® which may reduce microbial growth" De Boer et al (2025).
"For appropriately selected patients requiring admission-level care, ED-initiated OPAT can be a cost-saving substitute for hospitalization. Given limited safety data, benefits remain conditional on rigorous patient selection to avoid overuse and on structured early reassessment to mitigate early revisit risks" Chen et al (2025).
"When 0-1 risk factors are present, PICC insertion is safe even for patients with low platelet counts. If ≥ 2 risk factors exist, the decision to insert a PICC should consider the patient's clinical symptoms and needs. Blood product intervention does not affect the bleeding rate" Zhang et al (2025).
